I agree.
This was published last night in Nature Cancer, "Targeting the innate immune system in pediatric and adult AML."
https://www.nature.com/articles/s41375-024-02217-7
I've rewatched this presentation several times but its making a lot of sense.
https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02710995-69UCCL0B3668NS2PSD1Q0C53O2/pdf?access_token=0007rInP8VKAEnFJfs0cXGTQyMga
- Forums
- ASX - By Stock
- Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

I agree. This was published last night in Nature Cancer,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 14771167 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 243067 | 0.004 |
41 | 26897271 | 0.003 |
15 | 13950505 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14771167 | 22 |
0.006 | 13197211 | 14 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |